- Pages
- 3
- Published in
- India
Premium
Sun Pharma’s Gl0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-Metabolic and Lipid Lowering Efficacy in Individuals With Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions
2024
<Macro 'access_denied_modal'>
<Macro 'unauthorized_modal'>
Add to list
Citation
Sun Pharma (India), 2024. Sun Pharma’s Gl0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-Metabolic and Lipid Lowering Efficacy in Individuals With Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, Sun Pharma (India).
India.
Retrieved from https://coilink.org/20.500.12592/5je4ctz on 15 Nov 2024. COI: 20.500.12592/5je4ctz.
Full-page Screenshot
